Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$40.97 - $43.33 $11,717 - $12,392
286 Added 5.42%
5,560 $235,000
Q4 2023

Feb 14, 2024

SELL
$32.77 - $42.31 $33,785 - $43,621
-1,031 Reduced 16.35%
5,274 $220,000
Q3 2023

Nov 09, 2023

BUY
$35.46 - $40.13 $24,361 - $27,569
687 Added 12.23%
6,305 $237,000
Q2 2023

Aug 14, 2023

BUY
$24.24 - $40.97 $93,639 - $158,267
3,863 Added 220.11%
5,618 $213,000
Q4 2022

Feb 13, 2023

BUY
$27.6 - $32.99 $48,438 - $57,897
1,755 New
1,755 $50,000
Q2 2022

Aug 11, 2022

BUY
$35.0 - $43.59 $12,950 - $16,128
370 Added 26.71%
1,755 $63,000
Q4 2021

Feb 11, 2022

SELL
$47.6 - $65.0 $7,330 - $10,010
-154 Reduced 10.01%
1,385 $69,000
Q2 2021

Aug 11, 2021

BUY
$70.26 - $76.64 $59,158 - $64,530
842 Added 120.8%
1,539 $111,000
Q1 2021

May 13, 2021

SELL
$70.48 - $79.95 $610,427 - $692,446
-8,661 Reduced 92.55%
697 $0
Q3 2020

Nov 12, 2020

SELL
$54.41 - $68.2 $90,375 - $113,280
-1,661 Reduced 15.07%
9,358 $513,000
Q2 2020

Aug 13, 2020

SELL
$61.66 - $70.16 $474,597 - $540,021
-7,697 Reduced 41.13%
11,019 $733,000
Q1 2020

May 14, 2020

BUY
$59.35 - $88.73 $1.11 Million - $1.66 Million
18,716 New
18,716 $1.15 Million
Q4 2019

Feb 14, 2020

SELL
$74.18 - $97.92 $323,202 - $426,637
-4,357 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$75.36 - $86.57 $16,805 - $19,305
-223 Reduced 4.87%
4,357 $328,000
Q2 2019

Aug 14, 2019

BUY
$83.92 - $108.88 $18,714 - $24,280
223 Added 5.12%
4,580 $391,000
Q4 2018

Feb 14, 2019

SELL
$78.25 - $107.92 $644,936 - $889,476
-8,242 Reduced 65.42%
4,357 $368,000
Q3 2018

Dec 21, 2021

BUY
$97.82 - $116.09 $21,520 - $25,539
220 Added 1.78%
12,599 $1.24 Million
Q3 2018

Nov 14, 2018

BUY
$97.82 - $116.09 $786,179 - $933,015
8,037 Added 185.1%
12,379 $1.22 Million
Q2 2018

Aug 14, 2018

SELL
$97.62 - $120.59 $251,273 - $310,398
-2,574 Reduced 37.22%
4,342 $502,000
Q1 2018

Oct 18, 2019

BUY
$95.91 - $107.26 $213,112 - $238,331
2,222 Added 47.34%
6,916 $682,000
Q1 2018

May 15, 2018

SELL
$95.91 - $107.26 $114,996 - $128,604
-1,199 Reduced 20.35%
4,694 $462,000
Q4 2017

Feb 14, 2018

SELL
$104.5 - $126.38 $5.98 Million - $7.23 Million
-57,217 Reduced 90.66%
5,893 $616,000
Q3 2017

Nov 14, 2017

BUY
$97.26 - $116.2 $6.14 Million - $7.33 Million
63,110
63,110 $7.11 Million

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.